SG163512A1 - Novel pharmaceutical composition and its use in a method for treatment of patients with upper respiratory mucosal congestion - Google Patents

Novel pharmaceutical composition and its use in a method for treatment of patients with upper respiratory mucosal congestion

Info

Publication number
SG163512A1
SG163512A1 SG201004295-0A SG2010042950A SG163512A1 SG 163512 A1 SG163512 A1 SG 163512A1 SG 2010042950 A SG2010042950 A SG 2010042950A SG 163512 A1 SG163512 A1 SG 163512A1
Authority
SG
Singapore
Prior art keywords
pharmaceutical composition
treatment
upper respiratory
patients
novel pharmaceutical
Prior art date
Application number
SG201004295-0A
Inventor
Hartley Campbell Atkinson
Original Assignee
Aft Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aft Pharmaceuticals Ltd filed Critical Aft Pharmaceuticals Ltd
Priority to SG201004295-0A priority Critical patent/SG163512A1/en
Publication of SG163512A1 publication Critical patent/SG163512A1/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A PHARMACEUTICAL COMPOSITION ABSTRACT The present invention relates to a pharmaceutical composition including loratidine, its use in the treatment of upper respiratory mucosal congestion and a method of administration of the composition. Particularly, though not exclusively, the invention relates to a pharmaceutical composition including loratidine in an amount suitable for administration a maximum of 4 times a day, and a second active that is a hydroxyl-a-[(methylamino) methyl]-benzenemethanol, such 3-hydroxyl-a- [(methylamino) methyl]-benzenemethanol (phenylephrine), or salt thereof. No suitable Figure
SG201004295-0A 2005-06-17 2005-06-17 Novel pharmaceutical composition and its use in a method for treatment of patients with upper respiratory mucosal congestion SG163512A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SG201004295-0A SG163512A1 (en) 2005-06-17 2005-06-17 Novel pharmaceutical composition and its use in a method for treatment of patients with upper respiratory mucosal congestion

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SG201004295-0A SG163512A1 (en) 2005-06-17 2005-06-17 Novel pharmaceutical composition and its use in a method for treatment of patients with upper respiratory mucosal congestion

Publications (1)

Publication Number Publication Date
SG163512A1 true SG163512A1 (en) 2010-08-30

Family

ID=43064935

Family Applications (1)

Application Number Title Priority Date Filing Date
SG201004295-0A SG163512A1 (en) 2005-06-17 2005-06-17 Novel pharmaceutical composition and its use in a method for treatment of patients with upper respiratory mucosal congestion

Country Status (1)

Country Link
SG (1) SG163512A1 (en)

Similar Documents

Publication Publication Date Title
SG167657A1 (en) Novel medicament compositions based on tiotropium salts and on salmeterol salts
UA85708C2 (en) Benzoxazine-containing pharmaceutical combinations for treating respiratory tract diseases
MX338338B (en) Compositions and methods useful for treatment of respiratory illness.
EA201070121A1 (en) DOSAGE FORM CONTAINING A SLIP PROTEIN GLP-1-FC
RS52199B (en) Pharmaceutical compositions of a neuroactive steroid and uses thereof
DE502005010170D1 (en) NEW LOW-ACTIVE BETA-2 AGONISTS AND THEIR USE AS DRUGS
UY27755A1 (en) NEW PHARMACEUTICAL COMPOSITIONS BASED ON ANTICHOLINERGICS AND INHIBITORS.
NO20071505L (en) Method of Composition of Drug Delivery Devices.
MX2007003031A (en) Heteroaryl compounds for use as betamimetics in the treatment of respiratory diseases.
NZ593199A (en) Milnacipran for the long-term treatment of fybromyalgia syndrome
MX2010002498A (en) Methods of treating or preventing respiratory tract infection comprising administering cholecalciferol.
MY149601A (en) Masking the taste of powders
RS52867B (en) Combination therapy with glatiramer acetate and rasagiline for the treatment of multiple sclerosis
TNSN07263A1 (en) Substituted 4-phenyl tetrahydroisoquinolines, methods for producing them, their use as drug, and drug containing them
ATE302774T1 (en) MEDICINAL PRODUCTS CONTAINING BETAMIMETICS AND A NEW ANTICHOLINERGIC
ATE464045T1 (en) COMPOSITION OF LACTIC ACID AND LACTOFERRIN
ATE505203T1 (en) PHARMACEUTICAL COMBINATION OF ALISKIREN AND VALSARTAN
ATE499939T1 (en) NEW PHARMACEUTICAL COMPOSITIONS CONTAINING FLIBANSERIN POLYMORPHO A
HUP0203844A2 (en) Compound with growth hormone releasing properties, pharmaceutical composition containing it and its use
TW200640465A (en) New pharmaceutically active compounds for the treatment of respiratory diseases
DK1651270T3 (en) Medications for inhalation comprising betamimetics and an anticholinergic
GB2446341A (en) Method and system for transdermal drug delivery
SG163512A1 (en) Novel pharmaceutical composition and its use in a method for treatment of patients with upper respiratory mucosal congestion
WO2002069944A3 (en) Novel medicament compositions based on anticholinergics and on nk1 receptor antagonists
AR048460A1 (en) TREATMENT OF RESPIRATORY FUNCTION ALTERED WITH GABOXADOL